ICPT
Price
$19.01
Change
+$0.01 (+0.05%)
Updated
Nov 7, 3:59 PM EST
86 days until earnings call
SAGE
Price
$20.52
Change
-$0.32 (-1.54%)
Updated
Dec 5, 9:46 AM EST
79 days until earnings call
Ad is loading...

Analysis and predictions ICPT vs SAGE

Header iconICPT vs SAGE Comparison
Open Charts ICPT vs SAGEBanner chart's image
Intercept Pharmaceuticals
Price$19.01
Change+$0.01 (+0.05%)
Volume$37.16K
CapitalizationN/A
Sage Therapeutics
Price$20.52
Change-$0.32 (-1.54%)
Volume$100
CapitalizationN/A
View a ticker or compare two or three
ICPT vs SAGE Comparison Chart

Loading...

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
VS
ICPT vs. SAGE commentary
Dec 05, 2023

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ICPT is a Hold and SAGE is a Buy.

COMPARISON
Comparison
Dec 05, 2023
Stock price -- (ICPT: $19.00 vs. SAGE: $20.84)
Brand notoriety: ICPT and SAGE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ICPT: 144% vs. SAGE: 77%
Market capitalization -- ICPT: $794.69M vs. SAGE: $1.15B
ICPT [@Biotechnology] is valued at $794.69M. SAGE’s [@Biotechnology] market capitalization is $1.15B. The market cap for tickers in the [@Biotechnology] industry ranges from $464.61B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ICPT’s FA Score shows that 0 FA rating(s) are green whileSAGE’s FA Score has 0 green FA rating(s).

  • ICPT’s FA Score: 0 green, 5 red.
  • SAGE’s FA Score: 0 green, 5 red.
According to our system of comparison, ICPT is a better buy in the long-term than SAGE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SAGE’s TA Score shows that 5 TA indicator(s) are bullish.

  • SAGE’s TA Score: 5 bullish, 4 bearish.

Price Growth

ICPT (@Biotechnology) experienced а 0.00% price change this week, while SAGE (@Biotechnology) price change was +9.05% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +15.82%. For the same industry, the average monthly price growth was +28.00%, and the average quarterly price growth was +27.30%.

Reported Earning Dates

ICPT is expected to report earnings on Feb 29, 2024.

SAGE is expected to report earnings on Feb 22, 2024.

Industries' Descriptions

@Biotechnology (+15.82% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for ICPT with price predictions.
OPEN
A.I.dvisor published
a Summary for SAGE with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
SAGE($1.15B) has a higher market cap than ICPT($795M). ICPT YTD gains are higher at: 53.597 vs. SAGE (-45.359). ICPT has higher annual earnings (EBITDA): -48.22M vs. SAGE (-656.8M). SAGE has more cash in the bank: 876M vs. ICPT (323M). SAGE has less debt than ICPT: SAGE (6.97M) vs ICPT (224M). ICPT has higher revenues than SAGE: ICPT (318M) vs SAGE (11.3M).
ICPTSAGEICPT / SAGE
Capitalization795M1.15B69%
EBITDA-48.22M-656.8M7%
Gain YTD53.597-45.359-118%
P/E RatioN/A2.85-
Revenue318M11.3M2,814%
Total Cash323M876M37%
Total Debt224M6.97M3,215%
FUNDAMENTALS RATINGS
ICPT vs SAGE: Fundamental Ratings
ICPT
SAGE
OUTLOOK RATING
1..100
357
VALUATION
overvalued / fair valued / undervalued
1..100
72
Overvalued
55
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9797
PRICE GROWTH RATING
1..100
5064
P/E GROWTH RATING
1..100
10093
SEASONALITY SCORE
1..100
5010

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SAGE's Valuation (55) in the Pharmaceuticals Other industry is in the same range as ICPT (72). This means that SAGE’s stock grew similarly to ICPT’s over the last 12 months.

SAGE's Profit vs Risk Rating (100) in the Pharmaceuticals Other industry is in the same range as ICPT (100). This means that SAGE’s stock grew similarly to ICPT’s over the last 12 months.

SAGE's SMR Rating (97) in the Pharmaceuticals Other industry is in the same range as ICPT (97). This means that SAGE’s stock grew similarly to ICPT’s over the last 12 months.

ICPT's Price Growth Rating (50) in the Pharmaceuticals Other industry is in the same range as SAGE (64). This means that ICPT’s stock grew similarly to SAGE’s over the last 12 months.

SAGE's P/E Growth Rating (93) in the Pharmaceuticals Other industry is in the same range as ICPT (100). This means that SAGE’s stock grew similarly to ICPT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ICPTSAGE
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
N/A
Bearish Trend 1 day ago
69%
Momentum
ODDS (%)
N/A
Bullish Trend 1 day ago
77%
MACD
ODDS (%)
N/A
Bullish Trend 1 day ago
82%
TrendWeek
ODDS (%)
Bullish Trend 29 days ago
73%
Bullish Trend 1 day ago
74%
TrendMonth
ODDS (%)
Bullish Trend 29 days ago
71%
Bullish Trend 1 day ago
74%
Advances
ODDS (%)
N/A
Bullish Trend 1 day ago
74%
Declines
ODDS (%)
N/A
Bearish Trend 20 days ago
72%
BollingerBands
ODDS (%)
N/A
Bearish Trend 1 day ago
86%
Aroon
ODDS (%)
N/A
Bearish Trend 1 day ago
79%
View a ticker or compare two or three
Ad is loading...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
WQDGX9.750.03
+0.31%
WCM Quality Dividend Growth Investor
DYGAX13.17N/A
N/A
Meeder Dynamic Allocation Adviser
MMLRX13.16N/A
N/A
MassMutual Select TRP Large Cap Blend I
PEQYX14.77-0.06
-0.40%
Putnam Focused International Equity Y
DFETX17.19-0.10
-0.58%
DFA Emerging Markets II